|Description||AM 1235, a synthetic cannabimimetic indole derivative, is a potent and selective agonist for the cannabinoid receptor, with Ki values of 1.5 and 20.4 nM for the CB1 and CB2 receptors, respectively.|
|Solubility||Soluble in DMSO|
|Storage||Store at -20 °C|
|Application||A potent and selective agonist for the cannabinoid receptor|
|Quality Standard||Enterprise standard|
|Shelf Life||As supplied, 2 years from the QC date provided on the Certificate of Analysis, when stored properly.|
|Current Developer||SinSa Labs|
BML-190 is a selective cannabinoid CB2 receptor inverse agonist with Ki of 435 nM, with 50-fold selectivity over CB1 receptor.
MDA 19, a benzohydrazide derivative, has been found to be a CB2 receptor agonist and could be useful in reducting the Attenuates tactile allodynia of rats. IC50...
Tocrifluor T1117 is a fluorescent analog of AM 251, which is a GPR55 agonist and CB1 receptor antagonist. AM 251 conjugated with 5-carboxytetramethylrhodamine (...
Stearoyl ethanolamide is the ethanolamide of octadecanoic acid and an endocannabinoid neurotransmitter. It exhibits anorexic activity in mice.<br/>Nutritional s...
AM 2232, a synthetic cannabimimetic indole derivative, is a potent and selective agonist for the cannabinoid receptor, with Ki values of 0.28 and 1.48 nM for th...
Otenabant, also known as CP-945,598, is a drug which acts as a potent and highly selective CB1 antagonist. It was developed by Pfizer for the treatment of obesi...
Otenabant HCl is a selective and high affinity antagonist of CB1 with Ki value of 0.7 nM.
TC-C 14G is a potent and high affinity cannabinoid-1 (CB1) receptor inverse agonist (EC50 = 11 nM in cAMP assay; Ki = 4 nM).